Biotech SF: Shionogi

Showing posts with label Shionogi. Show all posts

Sunday, July 8, 2012

InterMune sued by partner Shionogi over Esbriet royalties in Europe

Intermune Inc. said it has been sued by Shionogi & Co. over royalties and license payments related to clinical trials of pirfenidone.

Brisbane-based Intermune (NASDAQ: ITMN) said Shionogi's complaint alleges that Intermune broke an agreement between the companies by using some of Shionogi's proprietary information in a regulatory application with the European Medicines Agency and then failing to pay royalties on sales of the drug there.

Subscribe to: Posts (Atom)

Some of my favorite stories.

• "The fight of his life" (2007)

Last year Mike Homer helped raise the money for 2,000 medical research computers. Now researchers are using that equipment in an attempt to save his life.

• "For reporter, CJD is more than a story" (2007)

Seven years ago -- nearly to the day -- my mother died of Creutzfeld-Jakob Disease.

• "A son's YouTube plea for Avastin" (2010)

Josh Turnage is your typical teenager, trying to discover what he wants to do in college and with his life. But a 7-minute, 41-second YouTube video he produced about his mother's fight with breast cancer may thrust him into a debate between drug makers and the agency that regulates them.

• "New device could knock out old dialysis technology" (2011)

Shuvo Roy has all the makings for the world's first implantable artificial kidney, thanks to nanotechnology and a web of nationwide collaborations.

All he needs now is $20 million.